康缘药业资产负债表_最新财务报告(600557.SH)_财务报表分析

	2024年三季报	2024年中报	2024年一季报	2023年年报	2023年三季报	2023年中报	2023年一季报
上市前/上市后	上市后	上市后	上市后	上市后	上市后	上市后	上市后
报表类型	合并报表	合并报表	合并报表	合并报表	合并报表	合并报表	合并报表
流动资产：
货币资金(元)	1,816,857,563.46	2,072,277,809.70	2,046,174,149.11	1,969,272,883.32	1,494,166,187.33	1,977,320,416.17	1,473,330,225.17
其中：交易性金融资产(元)	325,000,000.00	210,000,000.00	450,000,000.00	460,000,000.00	710,000,000.00	182,000,000.00	202,000,000.00
应收票据及应收账款(元)	652,710,094.78	654,057,500.26	695,435,384.39	653,766,073.68	660,177,912.42	664,315,148.43	712,926,236.56
其中：应收账款(元)	652,710,094.78	654,057,500.26	695,435,384.39	653,766,073.68	660,177,912.42	664,315,148.43	712,926,236.56
预付款项(元)	44,363,418.68	41,925,235.10	25,425,535.39	28,626,350.98	85,350,370.66	44,429,852.17	46,750,026.20
其他应收款(元)	2,842,561.90	12,055,048.14	13,735,844.26	5,315,921.09	7,927,617.64	12,412,154.35	13,350,947.05
存货(元)	546,132,223.92	503,529,046.01	395,815,182.73	350,108,245.14	361,300,292.35	338,605,472.61	368,473,901.98
持有待售资产(元)	-	-	-	67,038,559.99	-	-	-
其他流动资产(元)	6,681,775.79	72,206,990.79	58,585,240.58	73,361,887.19	1,893,157.41	7,626,723.29	50,249,227.91
流动资产合计(元)	3,730,071,208.27	3,900,536,632.87	4,222,203,715.69	4,049,719,426.38	3,631,010,304.81	3,771,501,855.17	3,687,497,602.57
非流动资产：
长期股权投资(元)	4,114,497.17	4,114,497.17	4,109,073.55	4,109,073.55	4,108,832.17	4,108,832.17	4,088,172.30
其他非流动金融资产(元)	11,210,107.40	11,210,107.40	11,210,107.40	11,210,107.40	18,729,806.40	25,581,468.40	31,243,255.82
固定资产(元)	2,266,913,709.32	2,216,612,851.70	2,243,783,439.56	2,280,740,570.47	2,341,926,388.89	2,358,309,047.14	2,380,801,172.83
在建工程(元)	318,779,434.99	283,845,544.57	254,922,876.61	227,250,218.26	197,700,912.56	134,286,081.80	110,567,135.57
无形资产(元)	170,354,732.17	176,823,021.73	190,305,473.33	197,380,959.08	214,469,762.18	216,224,986.01	224,204,581.03
开发支出(元)	181,500,752.87	177,592,549.86	172,766,086.80	171,701,113.32	165,962,371.46	168,798,172.20	166,673,459.43
商誉(元)	58,988,858.14	58,988,858.14	58,988,858.14	58,988,858.14	58,988,858.14	58,988,858.14	58,988,858.14
长期待摊费用(元)	12,066,595.33	12,845,479.90	13,624,364.49	14,403,249.06	15,280,735.82	16,059,721.59	17,109,789.14
递延所得税资产(元)	43,037,864.13	47,122,929.59	50,609,287.50	46,222,809.14	27,461,382.12	27,636,912.26	15,051,049.21
其他非流动资产(元)	105,701,791.85	164,555,125.94	157,447,890.13	55,595,282.72	20,228,520.67	22,857,441.03	21,974,407.29
非流动资产合计(元)	3,172,668,343.37	3,153,710,966.00	3,157,767,457.51	3,067,602,241.14	3,064,857,570.41	3,032,851,520.74	3,030,701,880.76
资产总计(元)	6,902,739,551.64	7,054,247,598.87	7,379,971,173.20	7,117,321,667.52	6,695,867,875.22	6,804,353,375.91	6,718,199,483.33
流动负债：
应付票据及应付账款(元)	145,272,571.69	230,926,714.92	253,754,564.94	228,418,638.90	204,236,140.05	230,337,890.17	297,810,893.87
其中：应付票据(元)	-	-	-	-	-	7,498,598.35	11,269,481.65
其中：应付账款(元)	145,272,571.69	230,926,714.92	253,754,564.94	228,418,638.90	204,236,140.05	222,839,291.82	286,541,412.22
合同负债(元)	15,610,563.69	18,553,584.87	16,097,493.32	25,165,640.90	13,837,025.08	29,311,766.86	46,867,940.71
应付职工薪酬(元)	18,082,362.06	12,486,551.70	8,002,074.65	25,726,012.38	32,804,820.54	25,836,273.75	20,383,809.60
应交税费(元)	75,789,914.18	52,899,975.06	59,581,584.51	70,666,290.59	70,801,663.81	68,035,275.74	28,873,651.45
应付股利(元)	-	-	-	-	-	128,611,549.44	-
其他应付款(元)	1,179,373,526.81	1,243,042,997.71	1,374,595,271.56	1,238,903,144.53	1,107,134,987.94	1,128,681,194.38	1,161,305,303.18
持有待售负债(元)	-	-	-	16,551,144.90	-	-	-
其他流动负债(元)	2,022,985.60	2,396,945.14	2,085,531.05	3,257,247.16	1,791,591.69	3,796,086.54	6,092,832.28
流动负债合计(元)	1,436,151,924.03	1,560,306,769.40	1,714,116,520.03	1,608,688,119.36	1,430,606,229.11	1,614,610,036.88	1,561,334,431.09
非流动负债：
长期应付款(元)	1,925,490.00	1,925,490.00	1,925,490.00	1,925,490.00	1,925,490.00	1,925,490.00	1,925,490.00
递延收益(元)	128,918,547.37	156,508,335.20	154,570,746.01	126,155,318.28	76,618,901.07	77,965,362.64	78,034,636.26
非流动负债合计(元)	130,844,037.37	158,433,825.20	156,496,236.01	128,080,808.28	78,544,391.07	79,890,852.64	79,960,126.26
负债合计(元)	1,566,995,961.40	1,718,740,594.60	1,870,612,756.04	1,736,768,927.64	1,509,150,620.18	1,694,500,889.52	1,641,294,557.35
所有者权益(或股东权益)：
实收资本或股本(元)	581,797,452.00	581,797,452.00	584,748,452.00	584,748,452.00	584,597,952.00	584,597,952.00	584,597,952.00
资本公积(元)	92,956,075.65	92,956,075.65	111,793,377.69	111,793,377.69	122,074,041.01	122,074,041.01	98,131,851.77
减：库存股(元)	210,094,122.29	120,002,291.37	62,255,152.00	48,135,010.00	64,698,480.00	64,698,480.00	64,698,480.00
盈余公积(元)	292,813,413.08	292,813,413.08	292,813,413.08	292,813,413.08	292,813,413.08	292,813,413.08	292,813,413.08
未分配利润(元)	4,392,678,207.64	4,300,956,522.94	4,399,621,756.70	4,251,576,797.98	4,064,264,460.33	3,990,459,077.93	3,984,788,117.91
归属于母公司股东权益合计(元)	5,150,151,026.08	5,148,521,172.30	5,326,721,847.47	5,192,797,030.75	4,999,051,386.42	4,925,246,004.02	4,895,632,854.76
少数股东权益(元)	185,592,564.16	186,985,831.97	182,636,569.69	187,755,709.13	187,665,868.62	184,606,482.37	181,272,071.22
股东权益合计(元)	5,335,743,590.24	5,335,507,004.27	5,509,358,417.16	5,380,552,739.88	5,186,717,255.04	5,109,852,486.39	5,076,904,925.98
负债和股东权益合计(元)	6,902,739,551.64	7,054,247,598.87	7,379,971,173.20	7,117,321,667.52	6,695,867,875.22	6,804,353,375.91	6,718,199,483.33
公告日期	2024-10-31	2024-07-27	2024-04-13	2024-03-11	2023-10-26	2023-07-13	2023-04-08
审计意见(境内)				标准无保留意见
原始财报文件下载	下载财报(PDF)	下载财报(PDF)	下载财报(PDF)	下载财报(PDF)	下载财报(PDF)	下载财报(PDF)	下载财报(PDF)


上市前/上市后
报表类型
流动资产：
货币资金(元)
其中：交易性金融资产(元)
应收票据及应收账款(元)
其中：应收账款(元)
预付款项(元)
其他应收款(元)
存货(元)
持有待售资产(元)
其他流动资产(元)
流动资产合计(元)
非流动资产：
长期股权投资(元)
其他非流动金融资产(元)
固定资产(元)
在建工程(元)
无形资产(元)
开发支出(元)
商誉(元)
长期待摊费用(元)
递延所得税资产(元)
其他非流动资产(元)
非流动资产合计(元)
资产总计(元)
流动负债：
应付票据及应付账款(元)
其中：应付票据(元)
其中：应付账款(元)
合同负债(元)
应付职工薪酬(元)
应交税费(元)
应付股利(元)
其他应付款(元)
持有待售负债(元)
其他流动负债(元)
流动负债合计(元)
非流动负债：
长期应付款(元)
递延收益(元)
非流动负债合计(元)
负债合计(元)
所有者权益(或股东权益)：
实收资本或股本(元)
资本公积(元)
减：库存股(元)
盈余公积(元)
未分配利润(元)
归属于母公司股东权益合计(元)
少数股东权益(元)
股东权益合计(元)
负债和股东权益合计(元)
公告日期
审计意见(境内)
原始财报文件下载

Showing 1 to 56 of 56 entries

资产负债表（康缘药业）

前瞻产业研究院